• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.03% Nasdaq Up0.33%

    Elite Pharmaceuticals, Inc. (ELTP)

    -OTC BB
    0.23 Up 0.00(1.17%) Jul 30, 3:58PM EDT
    |Pre-Market : NaN
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 1,234   1,363   1,256   1,162  
    Cost of Revenue904  700  682  729  
    Gross Profit 331   663   575   433  
    Operating Expenses
    Research Development4,849  2,293  3,565  4,020  
    Selling General and Administrative1,005  715  794  650  
    Non Recurring -   -   -   -  
    Others(67)213  277  194  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (5,457) (2,557) (4,061) (4,431)
    Income from Continuing Operations
    Total Other Income/Expenses Net(3,535)23,640  25,508  108  
    Earnings Before Interest And Taxes(8,992)21,083  21,447  (4,324)
    Interest Expense73  66  70  78  
    Income Before Tax(9,065)21,017  21,377  (4,402)
    Income Tax Expense -   -  (3) -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(9,065)21,017  21,380  (4,402)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (9,065) 21,017   21,380   (4,402)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (9,065) 21,017   21,380   (4,402)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.